Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study.
Seung Kak ShinYoung-Joo JinHannah RaOh Sang KwonJong Beom ShinYoung Joo JinSangheun LeeKi Jun HanYoung Nam KimTae Hun KimYun Soo KimJu Hyun KimPublished in: Journal of Korean medical science (2019)
DCV/ASV treatment for HCV GT1b infected patients without RAS achieved high SVR rates and showed durable SVR. Cirrhotic patients who achieved SVR12 showed the improvement of liver function and fibrosis markers.